Home-based Circuit Training for People With Intermittent Claudication
WALKSTRONG
Community WALKing and Home-baSed circuiT tRaining in peOple liviNG With Intermittent Claudication (WALK-STRONG): a Randomised Controlled Feasibility Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of the study is to assess the feasibility of undertaking a randomised controlled trial investigating the effectiveness of a 12-week home-based exercise programme for people with intermittent claudication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2021
CompletedFirst Posted
Study publicly available on registry
September 28, 2021
CompletedStudy Start
First participant enrolled
May 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2023
CompletedAugust 22, 2023
August 1, 2023
1.1 years
September 17, 2021
August 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Intervention feasibility assessed via recruitment rate
The investigators will record the number of eligible participants, as well as the number who enroll onto the study.
Will be evaluated after the intervention period (i.e.. 24 weeks after inclusion)
Intervention feasibility assessed via attrition rate
The investigators will record the number of protocol discontinuations and losses to follow-up.
Will be evaluated after the intervention period (i.e.. 24 weeks after inclusion)
Intervention feasibility assessed via protocol adherence
The investigators will examine discrepancies between intervention prescription and what is completed.
Will be evaluated after the intervention period (i.e.. 24 weeks after inclusion)
Intervention acceptability via participant interviews
One-to-one interviews will be held between an investigator and participant who has either completed the intervention, withdrawn or declined participation, to ask questions regarding the intervention protocol.
Will be evaluated after the intervention period (either at 12 week or 24 week follow up)
Secondary Outcomes (9)
12 and 24 week change in six-minute walk distance and pain-free walk distance
Baseline to 12 weeks and 24 weeks
12 and 24 week change in pain-free and maximal treadmill walk distance
Baseline to 12 weeks and 24 weeks
12 and 24 weeks change in left and right hand grip strength (via hand held dynamometer)
Baseline to 12 weeks and 24 weeks
12 and 24 week change in physical activity measured by accelerometer data
Baseline to 12 weeks and 24 weeks
12 and 24 week change in SF-36 score
Baseline to 12 weeks and 24 weeks
- +4 more secondary outcomes
Other Outcomes (3)
12 and 24 week change in rest times during a six-minute walk test
Baseline to 12 weeks and 24 weeks
12 and 24 week change in pain cessation following a treadmill test
Baseline to 12 weeks and 24 weeks
12 and 24 week changes in walking speed during a six-minute walk test
Baseline to 12 weeks and 24 weeks
Study Arms (2)
Exercise group
EXPERIMENTALHome-based circuit and community walking exercise
Usual care
NO INTERVENTIONUsual activity/healthcare
Interventions
The exercise group will receive a 12-week home-based exercise programme, with a wearable activity watch to regulate physical activity behaviour. This group will also receive biweekly telephone calls from the investigator.
Eligibility Criteria
You may qualify if:
- Ankle/brachial index (ABPI) \< 0.9 at rest or a drop of 20mmHg after exercise testing
- Ability to walk independently
- English speaking
- Able to follow instructions
- ≥ 18 years of age
You may not qualify if:
- Unable to provide informed consent
- Walking impairment for a reason that is not PAD
- Critical limb ischaemia
- Asymptomatic PAD
- Active cancer treatment
- Severe mental or physical limitations precluding participation safely in the home environment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Coventry University
Coventry, West Midlands, CV1 2DS, United Kingdom
Related Publications (1)
Waddell A, Denton F, Powell R, Broom DR, Birkett ST, McGregor G, Harwood AE. "It's put a routine and regimen in my life" - Participant experiences with a programme of community walking and home-based circuit training for intermittent claudication. J Vasc Nurs. 2024 Dec;42(4):276-281. doi: 10.1016/j.jvn.2024.09.003. Epub 2024 Sep 28.
PMID: 39645388DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander Waddell, MSc
Coventry University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
September 17, 2021
First Posted
September 28, 2021
Study Start
May 9, 2022
Primary Completion
June 26, 2023
Study Completion
June 26, 2023
Last Updated
August 22, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share